Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality...
Gespeichert in:
Veröffentlicht in: | International journal of hematology 2009-10, Vol.90 (3), p.374-377 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 377 |
---|---|
container_issue | 3 |
container_start_page | 374 |
container_title | International journal of hematology |
container_volume | 90 |
creator | Ando, Toshihiko Mitani, Noriyuki Matsui, Kumiko Yamashita, Koji Nomiyama, Jun Tsuru, Masatoshi Yujiri, Toshiaki Tanizawa, Yukio |
description | Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful. |
doi_str_mv | 10.1007/s12185-009-0385-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745902995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745729055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</originalsourceid><addsrcrecordid>eNqNkl2L1TAQhoso7rr6A7yRIIh6Uc1H06R4JcdPWBBEr8s0ne7JmibdJFXPz_OfmeM5uCAIC4FMmCfvZDJvVT1k9AWjVL1MjDMta0q7mooSiFvVKdNtCZRqblentOOylorRk-peSpeUMkUbdbc6YV3L9-u0-vUZzRoj-kzwZ44w47g6B3FHIjpYEpIwETBrRjLv0IUL9GFNxOH6DWcLBKaMkYD7k0FryBZnyGEJFnM5pYwzMegcKdo-LQ58hmyDJ9YTIEuJ96V_2LwleYvEbGOYQwozOAKDD7EENu9IfqZfcfacgB_J5o1s6yUkm-33krtf3ZnAJXxw3M-qr-_eftl8qM8_vf-4eX1eG9l0uVYMR9G0VLNOimlscQRQohVat62UoxhAm4kZMw7SAKIaAMAIOekBO9o0XJxVTw-6SwxXK6bczzbtWwOP5Ut61ciO8q6o34BUvKPyZiQVXHeFfPwPeRnW6EvDPWdKaKa1LhA7QCaGlCJO_RLtXIbZM9rvHdMfHNMXx_R7x_Si3Hl0FF6HMvzrG0eLFODJEYBkwE1ljsamvxznnBa5pnD8wKWS8hcYr1_4_-q_ARKv3N0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217381888</pqid></control><display><type>article</type><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</creator><creatorcontrib>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</creatorcontrib><description>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-009-0385-3</identifier><identifier>PMID: 19629629</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Biological and medical sciences ; Case Report ; CD56 Antigen - metabolism ; Chromosome aberrations ; Chromosomes, Human, Pair 21 ; Chromosomes, Human, Pair 8 ; Gastric Mucosa - pathology ; Graft vs Leukemia Effect ; Hematologic and hematopoietic diseases ; Hematology ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute - genetics ; Leukemia, Myeloid, Acute - pathology ; Leukemia, Myeloid, Acute - therapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical genetics ; Medical sciences ; Medicine ; Medicine & Public Health ; Oncology ; Recurrence ; Stomach Neoplasms - genetics ; Stomach Neoplasms - pathology ; Stomach Neoplasms - therapy ; Translocation, Genetic ; Transplantation, Homologous ; Young Adult</subject><ispartof>International journal of hematology, 2009-10, Vol.90 (3), p.374-377</ispartof><rights>The Japanese Society of Hematology 2009</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</citedby><cites>FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-009-0385-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-009-0385-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22200094$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19629629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ando, Toshihiko</creatorcontrib><creatorcontrib>Mitani, Noriyuki</creatorcontrib><creatorcontrib>Matsui, Kumiko</creatorcontrib><creatorcontrib>Yamashita, Koji</creatorcontrib><creatorcontrib>Nomiyama, Jun</creatorcontrib><creatorcontrib>Tsuru, Masatoshi</creatorcontrib><creatorcontrib>Yujiri, Toshiaki</creatorcontrib><creatorcontrib>Tanizawa, Yukio</creatorcontrib><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</description><subject>Biological and medical sciences</subject><subject>Case Report</subject><subject>CD56 Antigen - metabolism</subject><subject>Chromosome aberrations</subject><subject>Chromosomes, Human, Pair 21</subject><subject>Chromosomes, Human, Pair 8</subject><subject>Gastric Mucosa - pathology</subject><subject>Graft vs Leukemia Effect</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Leukemia, Myeloid, Acute - genetics</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>Leukemia, Myeloid, Acute - therapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Recurrence</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - therapy</subject><subject>Translocation, Genetic</subject><subject>Transplantation, Homologous</subject><subject>Young Adult</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkl2L1TAQhoso7rr6A7yRIIh6Uc1H06R4JcdPWBBEr8s0ne7JmibdJFXPz_OfmeM5uCAIC4FMmCfvZDJvVT1k9AWjVL1MjDMta0q7mooSiFvVKdNtCZRqblentOOylorRk-peSpeUMkUbdbc6YV3L9-u0-vUZzRoj-kzwZ44w47g6B3FHIjpYEpIwETBrRjLv0IUL9GFNxOH6DWcLBKaMkYD7k0FryBZnyGEJFnM5pYwzMegcKdo-LQ58hmyDJ9YTIEuJ96V_2LwleYvEbGOYQwozOAKDD7EENu9IfqZfcfacgB_J5o1s6yUkm-33krtf3ZnAJXxw3M-qr-_eftl8qM8_vf-4eX1eG9l0uVYMR9G0VLNOimlscQRQohVat62UoxhAm4kZMw7SAKIaAMAIOekBO9o0XJxVTw-6SwxXK6bczzbtWwOP5Ut61ciO8q6o34BUvKPyZiQVXHeFfPwPeRnW6EvDPWdKaKa1LhA7QCaGlCJO_RLtXIbZM9rvHdMfHNMXx_R7x_Si3Hl0FF6HMvzrG0eLFODJEYBkwE1ljsamvxznnBa5pnD8wKWS8hcYr1_4_-q_ARKv3N0</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Ando, Toshihiko</creator><creator>Mitani, Noriyuki</creator><creator>Matsui, Kumiko</creator><creator>Yamashita, Koji</creator><creator>Nomiyama, Jun</creator><creator>Tsuru, Masatoshi</creator><creator>Yujiri, Toshiaki</creator><creator>Tanizawa, Yukio</creator><general>Springer Japan</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20091001</creationdate><title>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</title><author>Ando, Toshihiko ; Mitani, Noriyuki ; Matsui, Kumiko ; Yamashita, Koji ; Nomiyama, Jun ; Tsuru, Masatoshi ; Yujiri, Toshiaki ; Tanizawa, Yukio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-71ed346081953fd6edaa7363886655d3ba8cf1ccdb5caee7baaac35f8be904423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Case Report</topic><topic>CD56 Antigen - metabolism</topic><topic>Chromosome aberrations</topic><topic>Chromosomes, Human, Pair 21</topic><topic>Chromosomes, Human, Pair 8</topic><topic>Gastric Mucosa - pathology</topic><topic>Graft vs Leukemia Effect</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Leukemia, Myeloid, Acute - genetics</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>Leukemia, Myeloid, Acute - therapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Recurrence</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - therapy</topic><topic>Translocation, Genetic</topic><topic>Transplantation, Homologous</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ando, Toshihiko</creatorcontrib><creatorcontrib>Mitani, Noriyuki</creatorcontrib><creatorcontrib>Matsui, Kumiko</creatorcontrib><creatorcontrib>Yamashita, Koji</creatorcontrib><creatorcontrib>Nomiyama, Jun</creatorcontrib><creatorcontrib>Tsuru, Masatoshi</creatorcontrib><creatorcontrib>Yujiri, Toshiaki</creatorcontrib><creatorcontrib>Tanizawa, Yukio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ando, Toshihiko</au><au>Mitani, Noriyuki</au><au>Matsui, Kumiko</au><au>Yamashita, Koji</au><au>Nomiyama, Jun</au><au>Tsuru, Masatoshi</au><au>Yujiri, Toshiaki</au><au>Tanizawa, Yukio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2009-10-01</date><risdate>2009</risdate><volume>90</volume><issue>3</issue><spage>374</spage><epage>377</epage><pages>374-377</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>Isolated extramedullary (EM) relapse of acute myelogenous leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare. Predisposing factors include CD56 expression and the chromosomal abnormality t(8;21). We describe an AML patient showing the chromosomal abnormality t(8;21) and CD56 expression who experienced a unique EM relapse after allo-HSCT. Approximately 10 months after allo-HSCT, he experienced relapse involving the femur and lumbar vertebrae and, subsequently, an EM relapse of the stomach. Although we administered only local radiotherapy and not systemic chemotherapy, he showed no bone marrow relapse on long-term follow-up after achieving complete hematological remission. These findings suggest that the graft-versus-leukemia effect may preferentially maintain marrow remission rather than prevent EM relapse. In addition, our findings show that extended survival is possible after EM relapse following allo-HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft-versus-leukemia effect may be useful.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>19629629</pmid><doi>10.1007/s12185-009-0385-3</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-5710 |
ispartof | International journal of hematology, 2009-10, Vol.90 (3), p.374-377 |
issn | 0925-5710 1865-3774 |
language | eng |
recordid | cdi_proquest_miscellaneous_745902995 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Biological and medical sciences Case Report CD56 Antigen - metabolism Chromosome aberrations Chromosomes, Human, Pair 21 Chromosomes, Human, Pair 8 Gastric Mucosa - pathology Graft vs Leukemia Effect Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical genetics Medical sciences Medicine Medicine & Public Health Oncology Recurrence Stomach Neoplasms - genetics Stomach Neoplasms - pathology Stomach Neoplasms - therapy Translocation, Genetic Transplantation, Homologous Young Adult |
title | Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A54%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20extramedullary%20relapse%20of%20acute%20myelogenous%20leukemia%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20in%20a%20patient%20with%20the%20chromosomal%20abnormality%20t(8;21)%20and%20CD56-positivity&rft.jtitle=International%20journal%20of%20hematology&rft.au=Ando,%20Toshihiko&rft.date=2009-10-01&rft.volume=90&rft.issue=3&rft.spage=374&rft.epage=377&rft.pages=374-377&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-009-0385-3&rft_dat=%3Cproquest_cross%3E745729055%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217381888&rft_id=info:pmid/19629629&rfr_iscdi=true |